Company profile for Novugen

PharmaCompass

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.A.E
Address
Address
Unit 3301, 33rd Floor, Jumeirah Business Center 4, Cluster N, Jumeirah Lakes T...
Telephone
Telephone
+971-4-277-3301
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

PEGS Boston Summit

PEGS Boston Summit

Not Confirmed

envelop Contact Supplier

PEGS Boston Summit

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219955

FDA
30 Oct 2025

https://www.prnewswire.com/news-releases/hikma-acquires-novugens-fda-approved-anda-for-trametinib-302431694.html

PR NEWSWIRE
17 Apr 2025

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218231

FDA
24 Apr 2024

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218012

FDA
21 Aug 2023

Drugs in Development

read-more
read-more

Details:

Through the acquisition, Hikma holds the rights of Mekinist-Generic (trametinib dimethyl sulfoxide) tablets from Novugen. It is being indicated for the treatment of BRAF-mutated melanoma.


Lead Product(s): Trametinib

Therapeutic Area: Oncology Brand Name: Mekinist-Generic

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Hikma Pharmaceuticals

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Acquisition April 17, 2025

blank

01

Novugen

U.A.E
arrow
PEGS Boston Summit
Not Confirmed

Novugen

U.A.E
arrow
PEGS Boston Summit
Not Confirmed

Details : Through the acquisition, Hikma holds the rights of Mekinist-Generic (trametinib dimethyl sulfoxide) tablets from Novugen. It is being indicated for the treatment of BRAF-mutated melanoma.

Product Name : Mekinist-Generic

Product Type : Miscellaneous

Upfront Cash : Undisclosed

April 17, 2025

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

01

Brand Name : ABIRATERONE ACETATE

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : ABIRATERONE ACETATE

PEGS Boston Summit
Not Confirmed
arrow

Novugen

Dosage Form : TABLET; ORAL

Proprietary Name : ABIRATERONE ACETATE

Dosage Strength : 250MG

Approval Date : 2022-01-05

Application Number : 215947

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

02

Brand Name : ABIRATERONE ACETATE

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : ABIRATERONE ACETATE

PEGS Boston Summit
Not Confirmed
arrow

Novugen

Dosage Form : TABLET; ORAL

Proprietary Name : ABIRATERONE ACETATE

Dosage Strength : 500MG

Approval Date : 2022-01-05

Application Number : 215947

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

03

Brand Name : EVEROLIMUS

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : EVEROLIMUS

PEGS Boston Summit
Not Confirmed
arrow

Novugen

Dosage Form : TABLET; ORAL

Proprietary Name : EVEROLIMUS

Dosage Strength : 2.5MG

Approval Date : 2025-10-30

Application Number : 219955

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

04

Brand Name : EVEROLIMUS

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : EVEROLIMUS

PEGS Boston Summit
Not Confirmed
arrow

Novugen

Dosage Form : TABLET; ORAL

Proprietary Name : EVEROLIMUS

Dosage Strength : 5MG

Approval Date : 2025-10-30

Application Number : 219955

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

05

Brand Name : EVEROLIMUS

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : EVEROLIMUS

PEGS Boston Summit
Not Confirmed
arrow

Novugen

Dosage Form : TABLET; ORAL

Proprietary Name : EVEROLIMUS

Dosage Strength : 7.5MG

Approval Date : 2025-10-30

Application Number : 219955

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

06

Brand Name : EVEROLIMUS

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : EVEROLIMUS

PEGS Boston Summit
Not Confirmed
arrow

Novugen

Dosage Form : TABLET; ORAL

Proprietary Name : EVEROLIMUS

Dosage Strength : 10MG

Approval Date : 2025-10-30

Application Number : 219955

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

07

Brand Name : LENALIDOMIDE

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : LENALIDOMIDE

PEGS Boston Summit
Not Confirmed
arrow

Novugen

Dosage Form : CAPSULE; ORAL

Proprietary Name : LENALIDOMIDE

Dosage Strength : 2.5MG

Approval Date : 2024-09-11

Application Number : 217281

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

08

Brand Name : LENALIDOMIDE

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : LENALIDOMIDE

PEGS Boston Summit
Not Confirmed
arrow

Novugen

Dosage Form : CAPSULE; ORAL

Proprietary Name : LENALIDOMIDE

Dosage Strength : 5MG

Approval Date : 2024-09-11

Application Number : 217281

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

09

Brand Name : LENALIDOMIDE

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : LENALIDOMIDE

PEGS Boston Summit
Not Confirmed
arrow

Novugen

Dosage Form : CAPSULE; ORAL

Proprietary Name : LENALIDOMIDE

Dosage Strength : 10MG

Approval Date : 2024-09-11

Application Number : 217281

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

10

Brand Name : LENALIDOMIDE

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : LENALIDOMIDE

PEGS Boston Summit
Not Confirmed
arrow

Novugen

Dosage Form : CAPSULE; ORAL

Proprietary Name : LENALIDOMIDE

Dosage Strength : 15MG

Approval Date : 2024-09-11

Application Number : 217281

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank
click full view

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact Novugen and get a quotation

Novugen is a supplier offers 3 products (APIs, Excipients or Intermediates).

Find Albendazole bulk with DMF offered by Novugen

Find Fingolimod Hydrochloride bulk with DMF offered by Novugen

Find Solifenacin Succinate bulk with DMF offered by Novugen

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty